Applied BioCode develops multiplex in‑vitro diagnostic panels that combine nucleic acid extraction with barcoded magnetic bead technology to detect dozens of respiratory (and other infectious) targets in a single assay.
Funding
$9.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical laboratories often need to test for multiple respiratory pathogens, but conventional assays require separate instruments, low sample throughput, and fixed test menus that can limit insurance reimbursement and increase operational costs.
Solution
Applied BioCode offers multiplex in‑vitro diagnostic panels that combine nucleic acid extraction with a barcoded magnetic bead (BMB) technology to detect dozens of respiratory targets in a single assay. The system integrates automated PCR amplification, hybridization, target capture, and detection, enabling high‑throughput processing of up to 188 samples per 8‑hour shift on a compact analyzer. Flexible data‑masking lets laboratories unmask only the pathogens ordered by clinicians, optimizing test menus for insurance coverage while preserving the ability to run comprehensive syndromic panels when needed. The platform is compatible with KingFisher™ Flex extraction, reducing instrument footprint and streamlining workflow across clinical and research settings.
Target Audience
Primary customers are clinical laboratories, hospital pathology departments, and research facilities that require rapid, cost‑effective multiplex testing for respiratory and other infectious disease panels.
Features
- Barcoded Magnetic Bead (BMB) technology that encodes target-specific probes for multiplex detection in a single reaction
- Integrated automation of nucleic acid extraction, PCR, hybridization, target capture, and fluorescence detection
- High‑throughput capacity: up to 188 patient samples processed in an 8‑hour shift
- Flexible data‑masking to enable selective reporting of pathogen targets based on physician orders, improving reimbursement potential
- Compatibility with KingFisher™ Flex nucleic acid extraction for streamlined sample preparation
- Ability to run multiple panels in parallel on a single instrument, supporting respiratory, gastrointestinal, fungal, and STI panels
- Compact analyzer design that eliminates the need for multiple dedicated instruments